Logo Image
News
Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Media
Expert ConnectionsTranslating TrialsCase-Based Peer PerspectivesPodcastsVideosShorts
Conferences
Conference CoverageConference Listing
Publications
More
CME/CE
Continuing Education
Resources
Case-Based Digest Rx Road MapEventsAdvanced Practice Corner
Partners

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Partners
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Liver Cancer
    • Gastric Cancers
  • Genitourinary Cancer
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head and Neck Cancers
  • Hematology
    • Leukemia
    • Graft-Vs-Host Disease
    • Myeloproliferative Neoplasms
    • Multiple Myeloma
    • Lymphoma
  • Lung Cancer
  • Pediatric Cancer
  • Sarcomas
  • Skin Cancer
    • Melanoma
Advertisement

Kristie Howlett, MS, RN

Advertisement

Articles by Kristie Howlett, MS, RN

Kristie Howlett on her Patient Hand Wiping Trial

ByKristie Howlett, MS, RN
July 26th 2011

Kristie Howlett from Sutter Roseville Medical Center on her Patient Hand Wiping Trial

Kristie Howlett on Patient Hand Wiping in an Oncology Unit

ByKristie Howlett, MS, RN
May 25th 2011

Kristie Howlett from the Sutter Roseville Medical Center on the Importance of Patient Hand Wiping

Advertisement

Latest Updated Articles

  • Kristie Howlett on Patient Hand Wiping in an Oncology Unit
    Kristie Howlett on Patient Hand Wiping in an Oncology Unit

    May 25th 2011

  • Kristie Howlett on her Patient Hand Wiping Trial
    Kristie Howlett on her Patient Hand Wiping Trial

    July 26th 2011



Advertisement
Advertisement

Trending on Oncology Nursing News

1

FDA Approves Frontline Sevabertinib for HER2-Mutant Advanced NSCLC Patients

2

FDA Grants Final Approval to Cabozantinib Capsules Across Multiple Solid Tumor Indications

3

Advocacy and Self-Care: Emily Beard on Oncology Navigation

4

FDA Approves Sevabertinib for HER2-Mutant Non-Small Cell Lung Cancer

5

Supporting Younger Patients with Metastatic Triple-Negative Breast Cancer

  • About Us
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • CureToday.com
  • OncLive.com
  • TargetedOnc.com
  • Advertise
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us